Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

472
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
472
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

357
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Angina IV: Management01:26

Angina IV: Management

372
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
372
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

404
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
404
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

541
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

425
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
425

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three-dimensional Rotational Angiography Assessment of Symptomatic Intracranial Atherosclerotic Disease Plaque Evolution under Medical Treatment.

Radiology·2026
Same author

A Portable Soft Robotic Glove with Fully Functional Thumb Assistance for Complex Dexterous Fine Motor Skills.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same author

Long-Term External Counterpulsation Reduces Beat-to-Beat Blood Pressure Variability Without Changing Arterial Blood Pressure in Ischemic Stroke: A Retrospective Case-Control Study.

Bioengineering (Basel, Switzerland)·2026
Same author

Body-wide multi-omic counteraction of aging with GLP-1R agonism.

Cell metabolism·2026
Same author

Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis.

Circulation·2026

Related Experiment Video

Updated: Mar 10, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

676

Angioplasty and Stenting.

Thomas W Leung, Ashley M Wabnitz, Zhongrong Miao

    Frontiers of Neurology and Neuroscience
    |December 14, 2016
    PubMed
    Summary

    Intracranial angioplasty and stenting offer options for recurrent strokes in intracranial atherosclerotic disease (ICAS). Careful patient selection based on stroke mechanism is vital for successful endovascular treatment.

    Area of Science:

    • Neurology
    • Interventional Neuroradiology
    • Vascular Medicine

    Background:

    • Recurrent strokes are common in intracranial atherosclerotic disease (ICAS) despite medical management.
    • Intracranial angioplasty and stenting are considered as adjunctive treatments for ICAS.
    • Cerebral artery anatomy presents unique challenges for endovascular procedures.

    Purpose of the Study:

    • To evaluate the role and patient selection for endovascular treatment in ICAS.
    • To highlight the importance of understanding ICAS pathophysiology for treatment decisions.
    • To discuss the benefits and risks of intracranial angioplasty and stenting.

    Main Methods:

    • Review of endovascular treatment considerations for ICAS.
    • Analysis of patient selection criteria based on stroke mechanisms.

    More Related Videos

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
    04:30

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

    Published on: May 14, 2013

    26.5K
    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
    07:25

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

    Published on: September 22, 2020

    3.8K

    Related Experiment Videos

    Last Updated: Mar 10, 2026

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
    06:59

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

    Published on: August 26, 2025

    676
    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
    04:30

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

    Published on: May 14, 2013

    26.5K
    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
    07:25

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

    Published on: September 22, 2020

    3.8K
  • Discussion of procedural challenges and specialized skills required.

    • Main Results:

    • Endovascular revascularization may benefit patients with territorial hypo-perfusion and high-grade lesions.
    • Atheromatous branch disease carries a risk of perforator stroke from endovascular intervention.
    • Joint evaluation by neurologists and neuro-interventionists is crucial for peri-operative care.

    Conclusions:

    • Patient selection is paramount for successful endovascular treatment of ICAS.
    • Understanding the diverse stroke mechanisms in ICAS guides treatment decisions.
    • The indication for endovascular treatment in ICAS is evolving with technological advancements.